Normally, pancreatic islet β-cells respond to increased metabolic demands by increasing their mass and insulin synthetic and secretory activity, as demonstrated both in rodent models of obesity without diabetes and in nondiabetic obese humans. The gene discussed is INS; the disease is diabetes mellitus.